Drug · DIN 02231035
BUSTAB
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since July 30, 2014; first marketed May 27, 1997.
- Drug Identification Number (DIN)
- 02231035
- Company (DIN owner)
- Valeant Canada LpLaval, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Buspirone N05BE01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BUSPIRONE HYDROCHLORIDE | 10 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 26, 2005: NOC 6621New Drug Submission (NDS) · Manufacturer name change
- April 3, 1997: NOC 3330New Drug Submission (NDS)
Other DINs named BUSTAB
- DIN 02231034 · Cancelled Post Market